Imaging Techniques in Alzheimer’s Disease: A Review of Applications in Early Diagnosis and Longitudinal Monitoring

Longitudinal 18F-FDG Images in Patients With Alzheimer Disease Over More Than 9 Years From a Preclinical Stage

(2020) Kenji Ishibashi et al.   CLINICAL NUCLEAR MEDICINE

Radiolabeling of [11C]FPS-ZM1, a receptor for advanced glycation end products-targeting positron emission tomography radiotracer, using a [11C]CO2-to-[11C]CO chemical conversion

(2020) Federico Luzi et al.   Future Medicinal Chemistry

Protofibrils of Amyloid-β are Important Targets of a Disease-Modifying Approach for Alzheimer’s Disease

(2020) Kenjiro Ono et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Longitudinal Amyloid-β PET in Atypical Alzheimer’s Disease and Frontotemporal Lobar Degeneration

(2020) Jennifer L. Whitwell et al.   JOURNAL OF ALZHEIMERS DISEASE

Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting

(2020) Yam Nath Paudel et al.   Cells

Longitudinal neuroimaging biomarkers differ across Alzheimer’s disease phenotypes

(2020) Irene Sintini et al.   BRAIN

Progress of RAGE Molecular Imaging in Alzheimer’s Disease

(2020) Yanyan Kong et al.   Frontiers in Aging Neuroscience

World Alzheimer Report 2019: Attitudes to dementia, a global survey

(2020) Chris Lynch   Alzheimers & Dementia

Longitudinal tau accumulation and atrophy in aging and alzheimer disease

(2019) Theresa M. Harrison et al.   ANNALS OF NEUROLOGY

Associations between tau, Aβ, and cortical thickness with cognition in Alzheimer disease

(2019) Rik Ossenkoppele et al.   NEUROLOGY

Optical coherence tomography angiography in preclinical Alzheimer’s disease

(2019) Jacoba Alida van de Kreeke et al.   BRITISH JOURNAL OF OPHTHALMOLOGY

Automated segmentation of medial temporal lobe subregions on in vivo T1-weighted MRI in early stages of Alzheimer's disease

(2019) Long Xie et al.   HUMAN BRAIN MAPPING

Bilateral volume reduction in posterior hippocampus in psychosis of epilepsy

(2019) James Allebone et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Progressive tau accumulation in Alzheimer’s disease: two-year follow-up study

(2019) Hanna Cho et al.   JOURNAL OF NUCLEAR MEDICINE

Imaging beta amyloid aggregation and iron accumulation in Alzheimer's disease using quantitative susceptibility mapping MRI

(2019) Nan-Jie Gong et al.   NEUROIMAGE

Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer’s Disease

(2019) Oskar Hansson et al.   Alzheimers Research & Therapy

Longitudinal neuroanatomical and cognitive progression of posterior cortical atrophy

(2019) Nicholas C Firth et al.   BRAIN

Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics

(2019) Sneham Tiwari et al.   International Journal of Nanomedicine

FDG-PET as an independent biomarker for Alzheimer’s biological diagnosis: a longitudinal study

(2019) Ya-Nan Ou et al.   Alzheimers Research & Therapy

Identification of Retinal Biomarkers in Alzheimer’s Disease Using Optical Coherence Tomography: Recent Insights, Challenges, and Opportunities

(2019) Delia Cabrera DeBuc et al.   Journal of Clinical Medicine

Topographical Heterogeneity of Alzheimer’s Disease Based on MR Imaging, Tau PET, and Amyloid PET

(2019) Seun Jeon et al.   Frontiers in Aging Neuroscience

Identification of the Early Stage of Alzheimer's Disease Using Structural MRI and Resting-State fMRI

(2019) Seyed Hani Hojjati et al.   Frontiers in Neurology

Propagation of Tau Pathology: Integrating Insights From Postmortem and In Vivo Studies

(2019) Thomas Vogels et al.   BIOLOGICAL PSYCHIATRY

Gray Matter Changes in Parkinson’s and Alzheimer’s Disease and Relation to Cognition

(2019) Lenka Krajcovicova et al.   Current Neurology and Neuroscience Reports

Three-year changes of cortical 18F-FDG in amnestic vs. non-amnestic sporadic early-onset Alzheimer’s disease

(2019) Matthieu Vanhoutte et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

A future for PET imaging in Alzheimer’s disease

(2019) Aurélie Kas et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Magnetic resonance imaging texture predicts progression to dementia due to Alzheimer disease earlier than hippocampal volume

(2019) Subin Lee et al.   JOURNAL OF PSYCHIATRY & NEUROSCIENCE

Different Positron Emission Tomography Tau Tracers Bind to Multiple Binding Sites on the Tau Fibril: Insight from Computational Modeling

(2018) N. Arul Murugan et al.   ACS Chemical Neuroscience

NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease

(2018) Clifford R. Jack et al.   Alzheimers & Dementia

Longitudinal tau PET in ageing and Alzheimer’s disease

(2018) Clifford R Jack et al.   BRAIN

Study of the Influence of Age in 18F-FDG PET Images Using a Data-Driven Approach and Its Evaluation in Alzheimer’s Disease

(2018) Jiehui Jiang et al.   Contrast Media & Molecular Imaging

Diagnostic utility of 18F-Fluorodeoxyglucose positron emission tomography (FDG-PET) in asymptomatic subjects at increased risk for Alzheimer’s disease

(2018) Alexander Drzezga et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Fluid and imaging biomarkers for Alzheimer's disease: Where we stand and where to head to

(2018) Adriane Dallanora Henriques et al.   EXPERIMENTAL GERONTOLOGY

Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study

(2018) Brian A Gordon et al.   LANCET NEUROLOGY

Peripheral Biomarkers for Early Detection of Alzheimer’s and Parkinson’s Diseases

(2018) Thein Than Htike et al.   MOLECULAR NEUROBIOLOGY

Longitudinal and cross-sectional structural magnetic resonance imaging correlates of AV-1451 uptake

(2018) Sandhitsu R. Das et al.   NEUROBIOLOGY OF AGING

Use of multimodality imaging and artificial intelligence for diagnosis and prognosis of early stages of Alzheimer's disease

(2018) Xiaonan Liu et al.   Translational Research

FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort

(2018) Silvia Paola Caminiti et al.   NeuroImage-Clinical

SPECT and PET imaging in Alzheimer’s disease

(2018) Varvara Valotassiou et al.   ANNALS OF NUCLEAR MEDICINE

Review and Meta-Analysis of Biomarkers and Diagnostic Imaging in Alzheimer's Disease

(2018) Lisa M. Bloudek et al.   JOURNAL OF ALZHEIMERS DISEASE

Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F-18]-T807

(2018) David T. Chien et al.   JOURNAL OF ALZHEIMERS DISEASE

Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F18]-T808

(2018) David T. Chien et al.   JOURNAL OF ALZHEIMERS DISEASE

Magnetic resonance imaging in Alzheimer’s disease and mild cognitive impairment

(2018) Avinash Chandra et al.   JOURNAL OF NEUROLOGY

Imaging the evolution and pathophysiology of Alzheimer disease

(2018) William Jagust   NATURE REVIEWS NEUROSCIENCE

PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases

(2018) Zhengxin Cai et al.   NEUROSCIENCE LETTERS

Questions concerning the role of amyloid-β in the definition, aetiology and diagnosis of Alzheimer’s disease

(2018) Gary P. Morris et al.   ACTA NEUROPATHOLOGICA

Data-driven approaches for tau-PET imaging biomarkers in Alzheimer's disease

(2018) Jacob W. Vogel et al.   HUMAN BRAIN MAPPING

Neuroimaging markers of global cognition in early Alzheimer's disease: A magnetic resonance imaging-electroencephalography study

(2018) Markus Waser et al.   Brain and Behavior

Automated and manual hippocampal segmentation techniques: Comparison of results, reproducibility and clinical applicability

(2018) Sona Hurtz et al.   NeuroImage-Clinical

Differential microstructural and morphological abnormalities in mild cognitive impairment and Alzheimer's disease: Evidence from cortical and deep gray matter

(2017) Nan-Jie Gong et al.   HUMAN BRAIN MAPPING

A Systematic Review of Longitudinal Studies Which Measure Alzheimer’s Disease Biomarkers

(2017) Emma Lawrence et al.   JOURNAL OF ALZHEIMERS DISEASE

Strategic roadmap for an early diagnosis of Alzheimer's disease based on biomarkers

(2017) Giovanni B Frisoni et al.   LANCET NEUROLOGY

Tau-imaging in neurodegeneration

(2017) Gérard N. Bischof et al.   METHODS

Tau PET imaging: present and future directions

(2017) Laure Saint-Aubert et al.   Molecular Neurodegeneration

Cryo-EM structures of tau filaments from Alzheimer’s disease

(2017) Anthony W. P. Fitzpatrick et al.   NATURE

[18F]FDG PET signal is driven by astroglial glutamate transport

(2017) Eduardo R Zimmer et al.   NATURE NEUROSCIENCE

18 F-FDG PET hypometabolism patterns reflect clinical heterogeneity in sporadic forms of early-onset Alzheimer's disease

(2017) Matthieu Vanhoutte et al.   NEUROBIOLOGY OF AGING

Alzheimer's disease as oligomeropathy

(2017) Kenjiro Ono   NEUROCHEMISTRY INTERNATIONAL

Aβ-amyloid and Tau Imaging in Dementia

(2017) Victor L. Villemagne et al.   SEMINARS IN NUCLEAR MEDICINE

Quantitative susceptibility mapping to evaluate the early stage of Alzheimer's disease

(2017) Hyug-Gi Kim et al.   NeuroImage-Clinical

Optical Coherence Tomography in Alzheimer’s Disease and Other Neurodegenerative Diseases

(2017) Jonah Doustar et al.   Frontiers in Neurology

Diagnostic Utility of Novel MRI-Based Biomarkers for Alzheimer's Disease: Diffusion Tensor Imaging and Deformation-Based Morphometry

(2017) Uwe Friese et al.   JOURNAL OF ALZHEIMERS DISEASE

Pre-Clinical Detection of Alzheimer's Disease Using FDG-PET, with or without Amyloid Imaging

(2017) Lisa Mosconi et al.   JOURNAL OF ALZHEIMERS DISEASE

Microstructural white matter alterations in preclinical Alzheimer’s disease detected using free water elimination diffusion tensor imaging

(2017) Andrew R. Hoy et al.   PLoS One

MRI morphometry in Alzheimer’s disease

(2016) Hiroshi Matsuda   AGEING RESEARCH REVIEWS

HYPOMETABOLISM PATTERNS USING FDG-PET IN TYPICAL AND ATYPICAL SPORADIC FORMS OF EARLY-ONSET ALZHEIMER'S DISEASE

(2016) Matthieu Vanhoutte et al.   Alzheimers & Dementia

Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria

(2016) Bruno Dubois et al.   Alzheimers & Dementia

Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study

(2016) Antoine Leuzy et al.   BRAIN

Longitudinal Positron Emission Tomography in Preventive Alzheimer's Disease Drug Trials, Critical Barriers from Imaging Science Perspective

(2016) Sepideh Shokouhi et al.   BRAIN PATHOLOGY

The amyloid hypothesis of Alzheimer's disease at 25 years

(2016) Dennis J Selkoe et al.   EMBO Molecular Medicine

Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer’s Dementia Using Quantitative Susceptibility Mapping Imaging

(2016) Yeonsil Moon et al.   JOURNAL OF ALZHEIMERS DISEASE

Pittsburgh Compound-B (PiB) binds amyloid β-protein protofibrils

(2016) Ghiam Yamin et al.   JOURNAL OF NEUROCHEMISTRY

In Vivo Comparison of Tau Radioligands 18 F-THK-5351 and 18 F-THK-5317

(2016) Tobey J. Betthauser et al.   JOURNAL OF NUCLEAR MEDICINE

A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers

(2016) Clifford R. Jack et al.   NEUROLOGY

Biomarkers for the Early Detection and Progression of Alzheimer’s Disease

(2016) Scott E. Counts et al.   Neurotherapeutics

Imaging synaptic density in the living human brain

(2016) Sjoerd J. Finnema et al.   Science Translational Medicine

Reference tissue normalization in longitudinal 18F-florbetapir positron emission tomography of late mild cognitive impairment

(2016) Sepideh Shokouhi et al.   Alzheimers Research & Therapy

The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features

(2015) Rik Ossenkoppele et al.   BRAIN

Is the Alzheimer’s disease cortical thickness signature a biological marker for memory?

(2015) Edgar Busovaca et al.   Brain Imaging and Behavior

Diagnostic accuracy of 18F amyloid PET tracers for the diagnosis of Alzheimer’s disease: a systematic review and meta-analysis

(2015) Elizabeth Morris et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

[18F]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer’s disease

(2015) Ryuichi Harada et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Atrophy patterns in early clinical stages across distinct phenotypes of Alzheimer's disease

(2015) Rik Ossenkoppele et al.   HUMAN BRAIN MAPPING

Comparison of Regional Gray Matter Atrophy, White Matter Alteration, and Glucose Metabolism as a Predictor of the Conversion to Alzheimer's Disease in Mild Cognitive Impairment

(2015) Bo Kyung Sohn et al.   JOURNAL OF KOREAN MEDICAL SCIENCE

PET Quantification of Tau Pathology in Human Brain with 11C-PBB3

(2015) Y. Kimura et al.   JOURNAL OF NUCLEAR MEDICINE

Measurement of Longitudinal  -Amyloid Change with 18F-Florbetapir PET and Standardized Uptake Value Ratios

(2015) S. M. Landau et al.   JOURNAL OF NUCLEAR MEDICINE

Improved Power for Characterizing Longitudinal Amyloid-  PET Changes and Evaluating Amyloid-Modifying Treatments with a Cerebral White Matter Reference Region

(2015) K. Chen et al.   JOURNAL OF NUCLEAR MEDICINE

18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease

(2015) R. Harada et al.   JOURNAL OF NUCLEAR MEDICINE

Tau imaging: early progress and future directions

(2015) Victor L Villemagne et al.   LANCET NEUROLOGY

Alzheimer's and Parkinson's diseases: The prion concept in relation to assembled A , tau, and  -synuclein

(2015) M. Goedert   SCIENCE

Evaluation of retinal nerve fiber layer thickness in Alzheimer disease usingspectral-domain optical coherence tomography

(2015) Alime GÜNEŞ et al.   Turkish Journal Of Medical Sciences

Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia

(2015) Chiara Cerami et al.   NeuroImage-Clinical

An evaluation of volume-based morphometry for prediction of mild cognitive impairment and Alzheimer's disease

(2015) Daniel Schmitter et al.   NeuroImage-Clinical

Longitudinal Assessment of Tau Pathology in Patients with Alzheimer’s Disease Using [18F]THK-5117 Positron Emission Tomography

(2015) Aiko Ishiki et al.   PLoS One

In vivo tau imaging: Obstacles and progress

(2014) Victor L. Villemagne et al.   Alzheimers & Dementia

Non-invasive assessment of Alzheimer’s disease neurofibrillary pathology using 18F-THK5105 PET

(2014) Nobuyuki Okamura et al.   BRAIN

Brain PET in the Diagnosis of Alzheimer’s Disease

(2014) Charles Marcus et al.   CLINICAL NUCLEAR MEDICINE

Diffusion tensor imaging in Alzheimer’s disease and affective disorders

(2014) Stefan J. Teipel et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

A distinct subfraction of Aβ is responsible for the high-affinity Pittsburgh compound B-binding site in Alzheimer's disease brain

(2014) Sergey V. Matveev et al.   JOURNAL OF NEUROCHEMISTRY

Radiosynthesis, Photoisomerization, Biodistribution, and Metabolite Analysis of 11C-PBB3 as a Clinically Useful PET Probe for Imaging of Tau Pathology

(2014) H. Hashimoto et al.   JOURNAL OF NUCLEAR MEDICINE

Automated Template-Based Hippocampal Segmentations from MRI: The Effects of 1.5T or 3T Field Strength on Accuracy

(2014) Kate E. Macdonald et al.   NEUROINFORMATICS

Imaging endpoints for clinical trials in Alzheimer’s disease

(2014) David M Cash et al.   Alzheimers Research & Therapy

Amyloid Imaging in Atypical Presentations of Alzheimer’s Disease

(2013) David A. Wolk   Current Neurology and Neuroscience Reports

Novel 18F-Labeled Arylquinoline Derivatives for Noninvasive Imaging of Tau Pathology in Alzheimer Disease

(2013) N. Okamura et al.   JOURNAL OF NUCLEAR MEDICINE

Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers

(2013) Clifford R Jack et al.   LANCET NEUROLOGY

Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study

(2013) Victor L Villemagne et al.   LANCET NEUROLOGY

Relevance of Magnetic Resonance Imaging for Early Detection and Diagnosis of Alzheimer Disease

(2013) Stefan J. Teipel et al.   MEDICAL CLINICS OF NORTH AMERICA

Brain  -amyloid load approaches a plateau

(2013) C. R. Jack et al.   NEUROLOGY

Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls

(2013) Masahiro Maruyama et al.   NEURON

Brain Imaging in Alzheimer Disease

(2013) K. A. Johnson et al.   Cold Spring Harbor Perspectives in Medicine

The Importance of Tau Phosphorylation for Neurodegenerative Diseases

(2013) Wendy Noble et al.   Frontiers in Neurology

Longitudinal imaging of Alzheimer pathology using [11C]PIB, [18F]FDDNP and [18F]FDG PET

(2012) Rik Ossenkoppele et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Increased functional connectivity within medial temporal lobe in mild cognitive impairment

(2012) Sandhitsu R. Das et al.   HIPPOCAMPUS

The development of effective biomarkers for Alzheimer's disease: a review

(2012) Mark S. Henry et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography

(2012) David A Wolk et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Therapeutic strategies for tau mediated neurodegeneration

(2012) Y. Yoshiyama et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Amyloid-  Imaging with Pittsburgh Compound B and Florbetapir: Comparing Radiotracers and Quantification Methods

(2012) S. M. Landau et al.   JOURNAL OF NUCLEAR MEDICINE

Cerebral PET with florbetapir compared with neuropathology at autopsy for detection of neuritic amyloid-β plaques: a prospective cohort study

(2012) Christopher M Clark et al.   LANCET NEUROLOGY

Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Clifford R. Jack et al.   Alzheimers & Dementia

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

(2011) Victor L. Villemagne et al.   ANNALS OF NEUROLOGY

In Vivo Fibrillar β-Amyloid Detected Using [11C]PiB Positron Emission Tomography and Neuropathologic Assessment in Older Adults

(2011) Jitka Sojkova et al.   ARCHIVES OF NEUROLOGY

Clinical Course of Patients with Familial Early-Onset Alzheimer’s Disease Potentially Lacking Senile Plaques Bearing the E693Δ Mutation in Amyloid Precursor Protein

(2011) Hiroyuki Shimada et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Effectiveness and Safety of 18F-FDG PET in the Evaluation of Dementia: A Review of the Recent Literature

(2011) N. I. Bohnen et al.   JOURNAL OF NUCLEAR MEDICINE

The potential of functional MRI as a biomarker in early Alzheimer's disease

(2011) Reisa Sperling   NEUROBIOLOGY OF AGING

Post-translational modifications of tau protein: Implications for Alzheimer's disease

(2011) Ludovic Martin et al.   NEUROCHEMISTRY INTERNATIONAL

Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults

(2011) B. C. Dickerson et al.   NEUROLOGY

Amyloid PET imaging in patients with mild cognitive impairment: A 2-year follow-up study

(2011) J. Koivunen et al.   NEUROLOGY

Alzheimer’s Disease Pathologic Cascades: Who Comes First, What Drives What

(2011) Russell H. Swerdlow   NEUROTOXICITY RESEARCH

Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plans

(2010) Paul S. Aisen et al.   Alzheimers & Dementia

Comparison of Neuropsychological and FDG-PET Findings between Early- versus Late-Onset Mild Cognitive Impairment: A Five-Year Longitudinal Study

(2010) Sook Hui Kim et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Pittsburgh Compound B (11C-PIB) and Fluorodeoxyglucose (18 F-FDG) PET in Patients With Alzheimer Disease, Mild Cognitive Impairment, and Healthy Controls

(2010) D.P. Devanand et al.   JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY

In Vivo Imaging of Amyloid Deposition in Alzheimer Disease Using the Radioligand 18F-AV-45 (Flobetapir F 18)

(2010) D. F. Wong et al.   JOURNAL OF NUCLEAR MEDICINE

Biomarkers for Alzheimer's disease: academic, industry and regulatory perspectives

(2010) Harald Hampel et al.   NATURE REVIEWS DRUG DISCOVERY

The clinical use of structural MRI in Alzheimer disease

(2010) Giovanni B. Frisoni et al.   Nature Reviews Neurology

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

(2010) Christopher C. Rowe et al.   NEUROBIOLOGY OF AGING

Alzheimer's Disease

(2010) Henry W. Querfurth et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fluorodeoxyglucose-Positron Emission Tomography in the differential diagnosis of early-onset dementia: a prospective, community-based study

(2009) Peter K Panegyres et al.   BMC Neurology

Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease

(2009) Marine Fouquet et al.   BRAIN

Mini-Mental State Examination Is Sensitive to Brain Atrophy in Alzheimer’s Disease

(2009) A.M. Fjell et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Biological markers of amyloid β-related mechanisms in Alzheimer's disease

(2009) Harald Hampel et al.   EXPERIMENTAL NEUROLOGY

Fully automatic hippocampus segmentation and classification in Alzheimer's disease and mild cognitive impairment applied on data from ADNI

(2009) Marie Chupin et al.   HIPPOCAMPUS

White Matter Hyperintensities and Cognitive Dysfunction in Alzheimer Disease

(2009) Jae-Hyeok Heo et al.   JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY

Comparison of 18F-FDG and PiB PET in Cognitive Impairment

(2009) V. J. Lowe et al.   JOURNAL OF NUCLEAR MEDICINE

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

(2009) Clifford R Jack et al.   LANCET NEUROLOGY

Brain atrophy associated with baseline and longitudinal measures of cognition

(2009) V.A. Cardenas et al.   NEUROBIOLOGY OF AGING

Alzheimer's Disease Neuroimaging Initiative (ADNI): Clinical characterization

(2009) R. C. Petersen et al.   NEUROLOGY

A new amyloid β variant favoring oligomerization in Alzheimer's-type dementia

(2008) Takami Tomiyama et al.   ANNALS OF NEUROLOGY

Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease

(2008) C. Patterson et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals

(2008) Bradford C. Dickerson et al.   CEREBRAL CORTEX

Imaging of amyloid β in Alzheimer's disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism

(2008) Christopher C Rowe et al.   LANCET NEUROLOGY

Animal models of Alzheimer's disease and frontotemporal dementia

(2008) Jürgen Götz et al.   NATURE REVIEWS NEUROSCIENCE

[11C]PIB-amyloid binding and levels of Aβ40 and Aβ42 in postmortem brain tissue from Alzheimer patients

(2008) Marie M. Svedberg et al.   NEUROCHEMISTRY INTERNATIONAL

Tensor-based morphometry as a neuroimaging biomarker for Alzheimer's disease: An MRI study of 676 AD, MCI, and normal subjects

(2008) Xue Hua et al.   NEUROIMAGE

Neuropsychological correlates of whole brain atrophy in Alzheimer's disease

(2008) J.M. Schott et al.   NEUROPSYCHOLOGIA

Variations in cortical thickness with dementia severity in Alzheimer's disease

(2008) Kiho Im et al.   NEUROSCIENCE LETTERS

Discrimination between Alzheimer Disease, Mild Cognitive Impairment, and Normal Aging by Using Automated Segmentation of the Hippocampus

(2008) Olivier Colliot et al.   RADIOLOGY

Whole-Brain Atrophy Rate and Cognitive Decline: Longitudinal MR Study of Memory Clinic Patients

(2008) Jasper D. Sluimer et al.   RADIOLOGY

Core candidate neurochemical and imaging biomarkers of Alzheimer’s disease

(2007) Harald Hampel et al.   Alzheimers & Dementia